Stay Updated with the Latest Newron Pharmaceuticals S.p.A. NWRN.SW News in Real Time
Find NWRN.SW news now at Meyka AI. Stay informed with the latest Newron Pharmaceuticals S.p.A. stocks updates, including price news, market analysis, and expert insights.
US Trade Deficit Hits $88.6B in July as AI Chip Imports Surge
US trade deficit reached $88.6 billion in July 2026, up 24% from June. AI-driven demand for semiconductors and computers pushed imports to record highs while exports fell 2.1%.
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review. This marks AstraZeneca’s second major trial halt…
2,500 Organizations Hit by LiteLLM Supply Chain Attack in March
LiteLLM supply chain attack in March 2026 exposed 2,500+ organizations and 434,000 CI/CD pipelines. Malicious code ran for 40 minutes, stealing AWS, GCP, and Azure credentials from major tech companies.
FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28
Major Pharmaceuticals recalls levothyroxine sodium tablets nationwide due to subpotency. The FDA classified it as a Class II recall on July 17. Affected patients should consult their doctor and return medication to the pharmacy.
Trump Imposes 12.5% Tariff on Australian Exports From July 25
Trump’s new 12.5% tariff on Australian exports takes effect July 25, replacing temporary 10% duty. Australia disputes forced labour claims and calls tariffs unjustified.
Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23
Generic Zyrtec recalled nationwide for cross-contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Call Rising Pharma at 1-844-874-7464.
Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23
Generic Zyrtec cetirizine tablets recalled nationwide due to cross-contamination with ranitidine heartburn drug. Four lot numbers affected, expiring October 2028. No adverse events reported yet.